Safety and efficacy of dual versus triple antithrombotic therapy (DAT vs TAT) in patients with atrial fibrillation following a PCI: a systematic review and network meta-analysis

OBJECTIVE: Creating an appropriate antithrombotic therapy for patients with atrial fibrillation (AF) who have undergone percutaneous coronary intervention (PCI) remains a dilemma. Several clinical trials compared the use of a dual antithrombotic therapy (DAT) regimen with a direct oral anticoagulant...

Descripción completa

Detalles Bibliográficos
Autores principales: Altoukhi, Renad M, Alshouimi, Reema A, Al Rammah, Shahad M, Alzahrani, Mohammed Y, Almutairi, Abdulaali R, Alshehri, Abdulmajeed M, Alfayez, Osamah M, Al Yami, Majed S, Almohammed, Omar A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526290/
https://www.ncbi.nlm.nih.gov/pubmed/32994232
http://dx.doi.org/10.1136/bmjopen-2019-036138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526290/
https://www.ncbi.nlm.nih.gov/pubmed/32994232
http://dx.doi.org/10.1136/bmjopen-2019-036138

Ejemplares similares